193 related articles for article (PubMed ID: 24816064)
1. In vitro modeling of the prostate cancer microenvironment.
Ellem SJ; De-Juan-Pardo EM; Risbridger GP
Adv Drug Deliv Rev; 2014 Dec; 79-80():214-21. PubMed ID: 24816064
[TBL] [Abstract][Full Text] [Related]
2. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis.
Bray LJ; Binner M; Holzheu A; Friedrichs J; Freudenberg U; Hutmacher DW; Werner C
Biomaterials; 2015; 53():609-20. PubMed ID: 25890757
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
4. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
5. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
Loessner D; Holzapfel BM; Clements JA
Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
[TBL] [Abstract][Full Text] [Related]
6. Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: A recent update on lung, breast and prostate cancer models.
Costard LS; Hosn RR; Ramanayake H; O'Brien FJ; Curtin CM
Acta Biomater; 2021 Sep; 132():360-378. PubMed ID: 33484910
[TBL] [Abstract][Full Text] [Related]
7. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
Miki J; Rhim JS
Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
[TBL] [Abstract][Full Text] [Related]
8. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
[TBL] [Abstract][Full Text] [Related]
9. Lessons from patient-derived xenografts for better in vitro modeling of human cancer.
Choi SY; Lin D; Gout PW; Collins CC; Xu Y; Wang Y
Adv Drug Deliv Rev; 2014 Dec; 79-80():222-37. PubMed ID: 25305336
[TBL] [Abstract][Full Text] [Related]
10. Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer.
Chitcholtan K; Asselin E; Parent S; Sykes PH; Evans JJ
Exp Cell Res; 2013 Jan; 319(1):75-87. PubMed ID: 23022396
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE
Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175
[TBL] [Abstract][Full Text] [Related]
12. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
[TBL] [Abstract][Full Text] [Related]
13. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
[TBL] [Abstract][Full Text] [Related]
14. Engineered silk fibroin protein 3D matrices for in vitro tumor model.
Talukdar S; Mandal M; Hutmacher DW; Russell PJ; Soekmadji C; Kundu SC
Biomaterials; 2011 Mar; 32(8):2149-59. PubMed ID: 21167597
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In Vitro Tumor Models.
Ferreira LP; Gaspar VM; Henrique R; Jerónimo C; Mano JF
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28834355
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional in vitro cancer models: a short review.
Wang C; Tang Z; Zhao Y; Yao R; Li L; Sun W
Biofabrication; 2014 Jun; 6(2):022001. PubMed ID: 24727833
[TBL] [Abstract][Full Text] [Related]
17. Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.
Msaouel P; Nandikolla G; Pneumaticos SG; Koutsilieris M
Expert Opin Investig Drugs; 2013 Nov; 22(11):1385-400. PubMed ID: 24024652
[TBL] [Abstract][Full Text] [Related]
18. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
19. Breaking through a roadblock in prostate cancer research: an update on human model systems.
Toivanen R; Taylor RA; Pook DW; Ellem SJ; Risbridger GP
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):122-31. PubMed ID: 22342674
[TBL] [Abstract][Full Text] [Related]
20. Establishment of two human prostate cancer cell lines derived from a single bone metastasis.
Navone NM; Olive M; Ozen M; Davis R; Troncoso P; Tu SM; Johnston D; Pollack A; Pathak S; von Eschenbach AC; Logothetis CJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2493-500. PubMed ID: 9815652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
